Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.

Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Abstract Text:

    jinwei huJinwei Hu,xiangpeng yuanXiangpeng Yuan,minhee k koMinHee K Ko,dali yinDali Yin,manuel r sacapanoManuel R Sacapano,xiao wangXiao Wang,bindu m kondaBindu M Konda,andres espinozaAndres Espinoza,ksenia prosolovichKsenia Prosolovich,john m ongJohn M Ong,dwain irvinDwain Irvin,keith l blackKeith L Black,

    BACKGROUND: The blood-brain tumor barrier (BTB) impedes the delivery of therapeutic agents to brain tumors. While adequate delivery of drugs occurs in systemic tumors, the BTB limits delivery of anti-tumor agents into brain metastases. RESULTS: In this study, we examined the function and regulation of calcium-activated potassium (KCa) channels in a rat metastatic brain tumor model. We showed that intravenous infusion of NS1619, a KCa channel agonist, and bradykinin selectively enhanced BTB permeability in brain tumors, but not in normal brain. Iberiotoxin, a KCa channel antagonist, significantly attenuated NS1619-induced BTB permeability increase. We found KCa channels and bradykinin type 2 receptors (B2R) expressed in cultured human metastatic brain tumor cells (CRL-5904, non-small cell lung cancer, metastasized to brain), human brain microvessel endothelial cells (HBMEC) and human lung cancer brain metastasis tissues. Potentiometric assays demonstrated the activity of KCa channels in metastatic brain tumor cells and HBMEC. Furthermore, we detected higher expression of KCa channels in the metastatic brain tumor tissue and tumor capillary endothelia as compared to normal brain tissue. Co-culture of metastatic brain tumor cells and brain microvessel endothelial cells showed an upregulation of KCa channels, which may contribute to the overexpression of KCa channels in tumor microvessels and selectivity of BTB opening. CONCLUSION: These findings suggest that KCa channels in metastatic brain tumors may serve as an effective target for biochemical modulation of BTB permeability to enhance selective delivery of chemotherapeutic drugs to metastatic brain tumors.

    Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Publishing Authors By Initials

    j huJ Hu,x yuanX Yuan,mk koMK Ko,d yinD Yin,mr sacapanoMR Sacapano,x wangX Wang,bm kondaBM Konda,a espinozaA Espinoza,k prosolovichK Prosolovich,jm ongJM Ong,d irvinD Irvin,kl blackKL Black,

    For similar xenograft model antitumor assays research abstracts see: xenograft model antitumor assays research

    PUBMED ID PMID:

    MEDLINE DATE:

    Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Molecular cancer

    VOLUME: 6

    Page Numbers: 22

    Journal Abbreviation: Mol. Cancer

    ISSN: 1476-4598

    DAY: 14

    MONTH: 03

    YEAR: 2007

    Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101147698

    Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Keywords Mesh Terms:

    KEYWORDS: Xenograft Model Antitumor Assays

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model. Information

    Substance Name: Receptor, Bradykinin B2

    Registry Number: 0

    Grant and Affiliation Information for Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.

    AFFILIATION: Department of Neurosurgery, Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. huj@cshs.org

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCRR

    GRANT: RR13707

    ACRONYM: RR

    MEDLINETA: Mol Cancer

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News